arrow
L

Lih-Ming Wong

St Vincent's Health
H指数:21
被引数:3,302

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma

动态免疫特征分析预测寡转移性肾细胞癌对放疗联合抗PD-1疗法的反应

2026-07-080
OAAI
A multicentre implementation trial of an Artificial Intelligence-driven biomarker to inform Shared decisions for androgen deprivation therapy in men undergoing prostate radiotherapy: the ASTuTE protocol

人工智能驱动的生物标志物的多中心实施试验,以告知接受前列腺放疗的男性雄激素剥夺治疗的共同决定: stute方案

2025-02-130
OAAI
Baseline Nodal Status on 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial

中高危前列腺癌男性68Ga-PSMA-11正电子发射断层扫描/计算机断层扫描的基线淋巴结状态是治疗失败的预后因素: proPSMA试验的随访

2024-11-290
OAAI
Fluorine-18-labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL)

氟18标记的前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描或磁共振成像诊断和定位前列腺癌。前瞻性单臂配对比较 (PEDAL)

2024-10-011
OA
Original Research Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival
2021-05-0117
PREAI
Patterns of disease detection using [18F]DCFPyL PET/CT imaging in patients with detectable PSA post prostatectomy being considered for salvage radiotherapy: a prospective trial
2021-04-1417
OAAI
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

高危前列腺癌患者行根治性手术或放疗前的前列腺特异性膜抗原pet-ct (proPSMA): 一项前瞻性、随机、多中心研究

LANCET
IF88.5
2020-04-011.2K
PREAI